Dual-isotope imaging reveals inter-individual differences in passive uptake of radiolabelled antibodies in tumours

Dual-isotope imaging reveals inter-individual differences in passive uptake of radiolabelled antibodies in tumours

Bibliografske podrobnosti
Main Authors:	Knight, J, Mosley, M, Kersemans, V, Allen, D, Smart, S, Cornelissen, B
Format:	Conference item
Izdano:	Springer Berlin Heidelberg 2018

Podobne knjige/članki

Dual-isotope imaging allows in vivo immunohistochemistry using radiolabelled antibodies in tumours
od: Knight, J, et al.
Izdano: (2019)

Imaging of pancreatic tumours in mice using radiolabelled anti-Claudin4 antibodies
od: Mosley, M, et al.
Izdano: (2016)

Imaging of claudin-4 in pancreatic ductal adenocarcinoma using a radiolabelled anti-claudin-4 monoclonal antibody
od: Torres, J, et al.
Izdano: (2017)

[18F]Olaparib: Precision radiolabelling of PARP inhibitors for in vivo imaging
od: Wilson, T, et al.
Izdano: (2018)

Tumor imaging using radiolabelled matrix metalloproteinase-activated anthrax proteins
od: Xavier, M, et al.
Izdano: (2019)

Microscale radiolabelling of antibodies with zirconium-89 for positron emission tomography
od: Knight, J, et al.
Izdano: (2015)

Scaling-down antibody radiolabeling reactions with zirconium-89
od: Knight, JC, et al.
Izdano: (2016)

A dual radiolabelling approach for tracking metal complexes: investigating the speciation of copper bis(thiosemicarbazonates) in vitro and in vivo.
od: Hueting, R, et al.
Izdano: (2015)

Radiolabeled cCPE peptides for SPECT imaging of claudin-4 overexpression in pancreatic cancer
od: Baguna-Torres, J, et al.
Izdano: (2020)

Uptake Assay for Radiolabeled Peptides in Yeast
od: Melinda Hauser, et al.
Izdano: (2016-11-01)

Radiolabelled Bacillus anthracis toxin-based probes for molecular imaging of MMP activity in tumour models
od: Xavier, M, et al.
Izdano: (2018)

Optimization by experimental design of precursor synthesis and radiolabeling of 2-iodo-L-phenylalanine, a novel amino acid for tumor imaging.
od: Kersemans, V, et al.
Izdano: (2006)

Treatment of advanced neuroendocrine tumours with radiolabelled somatostatin analogues.
od: Kaltsas, G, et al.
Izdano: (2005)

Targeting the tumour: Cell penetrating peptides for molecular imaging and radiotherapy
od: Kersemans, V, et al.
Izdano: (2010)

Biodistribution of a Radiolabeled Antibody in Mice as an Approach to Evaluating Antibody Pharmacokinetics
od: Kevin J. H. Allen, et al.
Izdano: (2018-12-01)

Immuno-imaging of ICAM-1 in tumours by SPECT
od: Mosley, M, et al.
Izdano: (2020)

Isotopic Radiolabeling of Crizotinib with Fluorine-18 for In Vivo Pet Imaging
od: Malvika Sardana, et al.
Izdano: (2022-12-01)

The value of radiolabelled MIBG and octreotide in the diagnosis and management of neuroendocrine tumours.
od: Kaltsas, G, et al.
Izdano: (2001)

123/125I-labelled 2-iodo-L: -phenylalanine and 2-iodo-D: -phenylalanine: comparative uptake in various tumour types and biodistribution in mice.
od: Kersemans, V, et al.
Izdano: (2006)

123I-EGF uptake in tumours predicts long-term farnesyltransferase therapy outcome in athymic mice
od: Cornelissen, B, et al.
Izdano: (2004)

Estimating Tumor/Non-Tumor Uptake from Radiolabeled Monoclonal Antibodies using Scintigraphic Images and Dissecting the Animal Models
od: Mojtaba Salouti, et al.
Izdano: (2010-12-01)

Influence of Several Compounds and Drugs on the Renal Uptake of Radiolabeled Affibody Molecules
od: Javad Garousi, et al.
Izdano: (2020-06-01)

Synthesis, biodistribution and effects of farnesyltransferase inhibitor therapy on tumour uptake in mice of 99mTc labelled epidermal growth factor.
od: Cornelissen, B, et al.
Izdano: (2005)

A DCE-MRI imaging-based model for simulation of vascular tumour growth
od: Roque, T, et al.
Izdano: (2016)

The Effect of VPA Treatment on Radiolabeled DOTATATE Uptake: Differences Observed In Vitro and In Vivo
od: Maria J. Klomp, et al.
Izdano: (2022-01-01)

Theragnostic Imaging Using Radiolabeled Antibodies and Tyrosine Kinase Inhibitors
od: Mitsuyoshi Yoshimoto, et al.
Izdano: (2015-01-01)

Approaches to Reducing Normal Tissue Radiation from Radiolabeled Antibodies
od: Hiroyuki Suzuki, et al.
Izdano: (2024-04-01)

Radionuclide treatment of neuroendocrine tumours with the novel radiolabelled analogue Y-90-SMT 487
od: Carroll, P, et al.
Izdano: (2003)

In vivo tumour imaging employing regional delivery of novel gallium radiolabelled polymer composites
od: Ross W. Stephens, et al.
Izdano: (2021-03-01)

Subcutaneous tumor volume measurement in the awake, manually restrained mouse using MRI.
od: Kersemans, V, et al.
Izdano: (2013)

Investigation of a Pharmacological Approach for Reduction of Renal Uptake of Radiolabeled ADAPT Scaffold Protein
od: Anzhelika Vorobyeva, et al.
Izdano: (2020-09-01)

Targeted killing of virally infected cells by radiolabeled antibodies to viral proteins.
od: Ekaterina Dadachova, et al.
Izdano: (2006-11-01)

Isotopic Radiolabeling of the Antiretroviral Drug [<sup>18</sup>F]Dolutegravir for Pharmacokinetic PET Imaging
od: Marion Tisseraud, et al.
Izdano: (2022-05-01)

Radiolabelled Bacillus anthracis toxin-based probes for molecular imaging of MMP activity in tumour models
od: Xavier, M
Izdano: (2018)

89Zr-anti-γH2AX-TAT but not 18F-FDG allows early monitoring of response to chemotherapy in a mouse model of pancreatic ductal adenocarcinoma
od: Knight, J, et al.
Izdano: (2017)

Early detection in a mouse model of pancreatic cancer by imaging DNA damage response signalling
od: Cornelissen, B, et al.
Izdano: (2019)

Detection of various tumour types in athymic mice with [123I]-2-Iodo-L-Phenylalanine and planar gamma camera acquisition
od: Kersemans, V, et al.
Izdano: (2004)

Reducing kidney uptake of radiolabelled exendin-4 using variants of the renally cleavable linker MVK
od: Belinda Trachsel, et al.
Izdano: (2023-09-01)

PET imaging of PARP expression using [18F]olaparib
od: Wilson, T, et al.
Izdano: (2018)

Early detection of pancreatic cancer in KPC mice by imaging DNA damage signalling
od: Knight, J, et al.
Izdano: (2018)